Wasatch Advisors holds 0.7% of Esperion stock
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Wasatch Advisors reports beneficial ownership of 1,930,185 Esperion Therapeutics shares, representing 0.7% of the company’s stock class. The position carries sole voting power and sole dispositive power over all of these shares, with no shared voting or dispositive authority.
The disclosure characterizes this stake as “Ownership of 5 percent or less of a class,” indicating that Wasatch Advisors holds a relatively small fraction of Esperion’s outstanding stock.
Key Figures
Key Terms
beneficially owned financial
sole power to vote financial
sole power to dispose or to direct the disposition of financial
Ownership of 5 percent or less of a class financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Wasatch Advisors report in Esperion Therapeutics (ESPR)?
What percentage of Esperion Therapeutics (ESPR) stock does Wasatch Advisors own?
What does “Ownership of 5 percent or less of a class” mean for ESPR in this report?
What class of Esperion (ESPR) securities does Wasatch Advisors hold and what is the CUSIP?
AI-generated analysis. How Rhea-AI works. Not financial advice.